Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Publication date: August 2011

Keywords : orthobiologic

Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Summary GlobalData’s new report, “Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017” provides key market data on the Orthobiologics market in the BRICS countries. The report provides value ($m) data for each segment within four market categories – Bone Graft Substitutes, Bone Allografts...

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles

» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Summary

GlobalData’s new report, “Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017” provides key market data on the Orthobiologics market in the BRICS countries. The report provides value ($m) data for each segment within four market categories – Bone Graft Substitutes, Bone Allografts, Viscosupplementation and Bone Growth Stimulators. The report also provides company shares and distribution shares data for the overall Orthobiologics market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world’s most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It’s estimated that shortly after 2020, India’s population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.

Scope

- Market size data for Orthobiologics market categories – Bone Graft Substitutes, Bone Allografts, Viscosupplementation and Bone Growth Stimulators.
- Annualized market revenues ($m) data for each of the segments and sub-segments within the four market categories. Data from 2003 to 2010, forecast forward for seven years to 2017.
- 2010 company shares and distribution shares data for the overall Orthobiologics market in each of the aforementioned countries.
- Global corporate-level profiles of key companies operating within the Orthobiologics market in BRICS.
- Key players covered include DePuy, Inc., Genzyme Corporation, Synthes, Inc., Orthofix International N.V., Medtronic, Inc., Biomet, Inc., DJO Incorporated, Smith & Nephew Plc, Baxter International Inc., Stryker Corporation, Globus Medical, Inc. and WRIGHT MEDICAL GROUP, INC.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Orthobiologics competitive landscape in BRICS.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Biomaterial Industry in Africa

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 13
2 Introduction 17
2.1 What is This Report About? 17
3 Orthobiologics in BRICS 18
3.1 Orthobiologics, BRICS, Overall Revenue ($m), 2003-2017 18
3.2 Orthobiologics, BRICS, Category Volume (Units), 2003-2017 24
3.3 Orthobiologics, BRICS, Company share (2009-2010) 29
4 Orthobiologics In Brazil 31
4.1 Orthobiologics, Brazil, Overall Revenue ($m), 2003-2017 31
4.2 Orthobiologics, Brazil, Category Volume (Units), 2003-2017 37
4.3 Bone Allografts in Brazil 41
4.3.1 Bone Allografts, Brazil, Overall Revenue (2003-2017) 41
4.4 Bone Graft Substitutes in Brazil 43
4.4.1 Bone Graft Substitutes, Brazil, Overall Revenue (2003-2017) 43
4.4.2 Bone Graft Substitutes, Brazil, Overall Volume (2003-2017) 47
4.4.3 Bone Graft Substitutes, Brazil, Average Price (2003-2017) 51
4.5 Viscosupplementation in Brazil 52
4.5.1 Viscosupplementation, Brazil, Overall Revenue (2003-2017) 52
4.5.2 Viscosupplementation, Brazil, Overall Volume (2003-2017) 54
4.5.3 Viscosupplementation, Brazil, Average Price (2003-2017) 56
4.6 Bone Growth Stimulators in Brazil 57
4.6.1 Bone Growth Stimulators, Brazil, Overall Revenue (2003-2017) 57
4.6.2 Bone Growth Stimulators, Brazil, Overall Volume (2003-2017) 59
4.6.3 Bone Growth Stimulators, Brazil, Average Price (2003-2017) 61
4.7 Orthobiologics, Brazil, Distribution Share (2009-2010) 62
4.8 Orthobiologics, Brazil, Company Share (2009-2010) 63
5 Orthobiologics In Russian Federation 65
5.1 Orthobiologics, Russian Federation, Overall Revenue ($m), 2003-2017 65
5.2 Orthobiologics, Russian Federation, Category Volume (Units), 2003-2017 71
5.3 Bone Graft Substitutes in Russian Federation 76
5.3.1 Bone Graft Substitutes, Russian Federation, Overall Revenue (2003-2017) 76
5.3.2 Bone Graft Substitutes, Russian Federation, Overall Volume (2003-2017) 80
5.3.3 Bone Graft Substitutes, Russian Federation, Average Price (2003-2017) 84
5.4 Bone Allografts in Russian Federation 85
5.4.1 Bone Allografts, Russian Federation, Overall Revenue (2003-2017) 85
5.5 Viscosupplementation in Russian Federation 87
5.5.1 Viscosupplementation, Russian Federation, Overall Revenue (2003-2017) 87
5.5.2 Viscosupplementation, Russian Federation, Overall Volume (2003-2017) 89
5.5.3 Viscosupplementation, Russian Federation, Average Price (2003-2017) 91
5.6 Bone Growth Stimulators In Russian Federation 92
5.6.1 Bone Growth Stimulators, Russian Federation, Overall Revenue (2003-2017) 92
5.6.2 Bone Growth Stimulators, Russian Federation, Overall Volume (2003-2017) 94
5.6.3 Bone Growth Stimulators, Russian Federation, Average Price (2003-2017) 96
5.7 Orthobiologics, Russian Federation, Distribution Share (2009-2010) 97
5.8 Orthobiologics, Russian Federation, Company Share (2009-2010) 98
6 Orthobiologics In India 100
6.1 Orthobiologics, India, Overall Revenue ($m), 2003-2017 100
6.2 Orthobiologics, India, Category Volume (Units), 2003-2017 106
6.3 Bone Graft Substitutes in India 110
6.3.1 Bone Graft Substitutes, India, Overall Revenue (2003-2017) 110
6.3.2 Bone Graft Substitutes, India, Overall Volume (2003-2017) 114
6.3.3 Bone Graft Substitutes, India, Average Price (2003-2017) 117
6.4 Viscosupplementation In India 118
6.4.1 Viscosupplementation, India, Overall Revenue (2003-2017) 118
6.4.2 Viscosupplementation, India, Overall Volume (2003-2017) 120
6.4.3 Viscosupplementation, India, Average Price (2003-2017) 122
6.5 Bone Allografts In India 123
6.5.1 Bone Allografts, India, Overall Revenue (2003-2017) 123
6.6 Bone Growth Stimulators in India 125
6.6.1 Bone Growth Stimulators, India, Overall Revenue (2003-2017) 125
6.6.2 Bone Growth Stimulators, India, Overall Volume (2003-2017) 127
6.6.3 Bone Growth Stimulators, India, Average Price (2003-2017) 129
6.7 Orthobiologics, India, Distribution Share (2009-2010) 130
6.8 Orthobiologics, India, Company Share (2009-2010) 131
7 Orthobiologics In China 133
7.1 Orthobiologics, China, Overall Revenue ($m), 2003-2017 133
7.2 Orthobiologics, China, Category Volume (Units), 2003-2017 139
7.3 Bone Graft Substitutes In China 144
7.3.1 Bone Graft Substitutes, China, Overall Revenue (2003-2017) 144
7.3.2 Bone Graft Substitutes, China, Overall Volume (2003-2017) 148
7.3.3 Bone Graft Substitutes, China, Average Price (2003-2017) 152
7.4 Bone Allografts in China 153
7.4.1 Bone Allografts, China, Overall Revenue (2003-2017) 153
7.5 Viscosupplementation In China 155
7.5.1 Viscosupplementation, China, Overall Revenue (2003-2017) 155
7.5.2 Viscosupplementation, China, Overall Volume (2003-2017) 157
7.5.3 Viscosupplementation, China, Average Price (2003-2017) 159
7.6 Bone Growth Stimulators In China 160
7.6.1 Bone Growth Stimulators, China, Overall Revenue (2003-2017) 160
7.6.2 Bone Growth Stimulators, China, Overall Volume (2003-2017) 162
7.6.3 Bone Growth Stimulators, China, Average Price (2003-2017) 164
7.7 Orthobiologics, China, Distribution Share (2009-2010) 165
7.8 Orthobiologics, China, Company Share (2009-2010) 166
8 Orthobiologics In South Africa 168
8.1 Orthobiologics, South Africa, Overall Revenue ($m), 2003-2017 168
8.2 Orthobiologics, South Africa, Category Volume (Units), 2003-2017 174
8.3 Viscosupplementation In South Africa 179
8.3.1 Viscosupplementation, South Africa, Overall Revenue (2003-2017) 179
8.3.2 Viscosupplementation, South Africa, Overall Volume (2003-2017) 181
8.3.3 Viscosupplementation, South Africa, Average Price (2003-2017) 183
8.4 Bone Graft Substitutes in South Africa 184
8.4.1 Bone Graft Substitutes, South Africa, Overall Revenue (2003-2017) 184
8.4.2 Bone Graft Substitutes, South Africa, Overall Volume (2003-2017) 188
8.4.3 Bone Graft Substitutes, South Africa, Average Price (2003-2017) 191
8.5 Bone Allografts in South Africa 192
8.5.1 Bone Allografts, South Africa, Overall Revenue (2003-2017) 192
8.6 Bone Growth Stimulators In South Africa 194
8.6.1 Bone Growth Stimulators, South Africa, Overall Revenue (2003-2017) 194
8.6.2 Bone Growth Stimulators, South Africa, Overall Volume (2003-2017) 196
8.6.3 Bone Growth Stimulators, South Africa, Average Price (2003-2017) 198
8.7 Orthobiologics, South Africa, Distribution Share (2009-2010) 199
8.8 Orthobiologics, South Africa, Company Share (2009-2010) 200
9 Overview of Key Companies in BRICS Orthobiologics Market 202
9.1 DePuy, Inc. 202
9.1.1 Company Overview 202
9.1.2 Share in the BRICS Orthobiologics Market 203
9.2 Genzyme Corporation 204
9.2.1 Company Overview 204
9.2.2 Share in the BRICS Orthobiologics Market 205
9.3 Synthes, Inc. 206
9.3.1 Company Overview 206
9.3.2 Share in the BRICS Orthobiologics Market 207
9.4 Orthofix International N.V. 208
9.4.1 Company Overview 208
9.4.2 Share in the BRICS Orthobiologics Market 209
9.5 Medtronic, Inc. 210
9.5.1 Company Overview 210
9.5.2 Share in the BRICS Orthobiologics Market 211
9.6 Biomet, Inc. 212
9.6.1 Company Overview 212
9.6.2 Share in the BRICS Orthobiologics Market 213
9.7 DJO Incorporated 214
9.7.1 Company Overview 214
9.7.2 Share in the BRICS Orthobiologics Market 215
9.8 Smith & Nephew Plc 216
9.8.1 Company Overview 216
9.8.2 Share in the BRICS Orthobiologics Market 217
9.9 Baxter International Inc. 218
9.9.1 Company Overview 218
9.9.2 Share in the BRICS Orthobiologics Market 219
9.10 Stryker Corporation 220
9.10.1 Company Overview 220
9.10.2 Share in the BRICS Orthobiologics Market 221
9.11 Globus Medical, Inc. 222
9.11.1 Company Overview 222
9.11.2 Share in the BRICS Orthobiologics Market 222
9.12 Wright Medical Group, Inc 223
9.12.1 Company Overview 223
9.12.2 Share in the BRICS Orthobiologics Market 224
9.13 Alphatec Holdings, Inc. 225
9.13.1 Company Overview 225
9.14 Ferring Pharmaceuticals 225
9.14.1 Company Overview 225
9.15 Seikagaku Corporation 225
9.15.1 Company Overview 225
9.16 Osteotech, Inc. (Inactive) 226
9.16.1 Company Overview 226
10 Appendix 227
10.1 Definitions of Markets Covered in the Report 228
10.1.1 Orthobiologics 228
10.2 Research Methodology 230
10.3 Secondary Research 230
10.4 Primary Research 231
10.5 Models 231
10.6 Forecasts 232
10.7 Expert Panels 232
10.8 GlobalData Consulting 232
10.9 Currency Conversion 233
10.10 Contact Us 233
10.11 Disclaimer 233

1.1 List of Tables

Table 1: Orthobiologics, BRICS, Overall Revenue ($m), 2003-2017 19
Table 2: Orthobiologics, BRICS, Overall Revenue ($m), Historic, 2003-2010 21
Table 3: Orthobiologics, BRICS, Overall Revenue ($m), Forecast, 2010-2017 23
Table 4: Orthobiologics, BRICS, Category Volume (Units), 2003-2017 24
Table 5: Orthobiologics, BRICS, Category Volume (Units), Historic, 2003-2010 26
Table 6: Orthobiologics, BRICS, Category Volume (Units), Forecast, 2010-2017 28
Table 7: Orthobiologics, BRICS, Company share by Revenue ($m), 2009-2010 30
Table 8: Orthobiologics, Brazil, Overall Revenue ($m), 2003-2017 32
Table 9: Orthobiologics, Brazil, Overall Revenue ($m), Historic, 2003-2010 34
Table 10: Orthobiologics, Brazil, Overall Revenue ($m), Forecast, 2010-2017 36
Table 11: Orthobiologics, Brazil, Category Volume (Units), 2003-2017 37
Table 12: Orthobiologics, Brazil, Category Volume (Units), Historic, 2003-2010 39
Table 13: Orthobiologics, Brazil, Category Volume (Units), Forecast, 2010-2017 40
Table 14: Bone Allografts, Brazil, Revenue ($m), Historic, 2003-2010 41
Table 15: Bone Allografts, Brazil, Revenue ($m), Forecast, 2010-2017 42
Table 16: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, Historic, 2003-2010 44
Table 17: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, Forecast, 2010-2017 46
Table 18: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Historic, 2003-2010 48
Table 19: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Forecast, 2010-2017 50
Table 20: Bone Graft Substitutes, Brazil, Average Price ($), Historic, 2003-2010 51
Table 21: Bone Graft Substitutes, Brazil, Average Price ($), Forecast, 2010-2017 51
Table 22: Viscosupplementation, Brazil, Revenue ($m), Historic, 2003-2010 52
Table 23: Viscosupplementation, Brazil, Revenue ($m), Forecast, 2010-2017 53
Table 24: Viscosupplementation, Brazil, Volume (Units), Historic, 2003-2010 54
Table 25: Viscosupplementation, Brazil, Volume (Units), Forecast, 2010-2017 55
Table 26: Viscosupplementation, Brazil, Average Price ($), Historic, 2003-2010 56
Table 27: Viscosupplementation, Brazil, Average Price ($), Forecast, 2010-2017 56
Table 28: Bone Growth Stimulators, Brazil, Revenue ($m), Historic, 2003-2010 57
Table 29: Bone Growth Stimulators, Brazil, Revenue ($m), Forecast, 2010-2017 58
Table 30: Bone Growth Stimulators, Brazil, Volume (Units), Historic, 2003-2010 59
Table 31: Bone Growth Stimulators, Brazil, Volume (Units), Forecast, 2010-2017 60
Table 32: Bone Growth Stimulators, Brazil, Average Price ($), Historic, 2003-2010 61
Table 33: Bone Growth Stimulators, Brazil, Average Price ($), Forecast, 2010-2017 61
Table 34: Orthobiologics, Brazil, Distribution Share by Revenue ($m), 2009-2010 62
Table 35: Orthobiologics, Brazil, Company Share by Revenue ($m), 2009-2010 64
Table 36: Orthobiologics, Russian Federation, Overall Revenue ($m), 2003-2017 66
Table 37: Orthobiologics, Russian Federation, Overall Revenue ($m), Historic, 2003-2010 68
Table 38: Orthobiologics, Russian Federation, Overall Revenue ($m), Forecast, 2010-2017 70
Table 39: Orthobiologics, Russian Federation, Category Volume (Units), 2003-2017 71
Table 40: Orthobiologics, Russian Federation, Category Volume (Units), Historic, 2003-2010 73
Table 41: Orthobiologics, Russian Federation, Category Volume (Units), Forecast, 2010-2017 75
Table 42: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 77
Table 43: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 79
Table 44: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Historic, 2003-2010 81
Table 45: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Forecast, 2010-2017 83
Table 46: Bone Graft Substitutes, Russian Federation, Average Price ($), Historic, 2003-2010 84
Table 47: Bone Graft Substitutes, Russian Federation, Average Price ($), Forecast, 2010-2017 84
Table 48: Bone Allografts, Russian Federation, Revenue ($m), Historic, 2003-2010 85
Table 49: Bone Allografts, Russian Federation, Revenue ($m), Forecast, 2010-2017 86
Table 50: Viscosupplementation, Russian Federation, Revenue ($m), Historic, 2003-2010 87
Table 51: Viscosupplementation, Russian Federation, Revenue ($m), Forecast, 2010-2017 88
Table 52: Viscosupplementation, Russian Federation, Volume (Units) Historic, 2003-2010 89
Table 53: Viscosupplementation, Russian Federation, Volume (Units), Forecast, 2010-2017 90
Table 54: Viscosupplementation, Russian Federation, Average Price ($), Historic, 2003-2010 91
Table 55: Viscosupplementation, Russian Federation, Average Price ($), Forecast, 2010-2017 91
Table 56: Bone Growth Stimulators, Russian Federation, Revenue ($m), Historic, 2003-2010 92
Table 57: Bone Growth Stimulators, Russian Federation, Revenue ($m), Forecast, 2010-2017 93
Table 58: Bone Growth Stimulators, Russian Federation, Volume (Units), Historic, 2003-2010 94
Table 59: Bone Growth Stimulators, Russian Federation, Volume (Units), Forecast, 2010-2017 95
Table 60: Bone Growth Stimulators, Russian Federation, Average Price ($), Historic, 2003-2010 96
Table 61: Bone Growth Stimulators, Russian Federation, Average Price ($), Forecast, 2010-2017 96
Table 62: Orthobiologics, Russian Federation, Distribution Share by Revenue ($m), 2009-2010 97
Table 63: Orthobiologics, Russian Federation, Company Share by Revenue ($m), 2009-2010 99
Table 64: Orthobiologics, India, Overall Revenue ($m), 2003-2017 101
Table 65: Orthobiologics, India, Overall Revenue ($m), Historic, 2003-2010 103
Table 66: Orthobiologics, India, Overall Revenue ($m), Forecast, 2010-2017 105
Table 67: Orthobiologics, India, Category Volume (Units), 2003-2017 106
Table 68: Orthobiologics, India, Category Volume (Units), Historic, 2003-2010 108
Table 69: Orthobiologics, India, Category Volume (Units), Forecast, 2010-2017 109
Table 70: Bone Graft Substitutes, India, Revenue ($m) by Segment, Historic, 2003-2010 111
Table 71: Bone Graft Substitutes, India, Revenue ($m) by Segment, Forecast, 2010-2017 113
Table 72: Bone Graft Substitutes, India, Volume (Units) by Segment, Historic, 2003-2010 115
Table 73: Bone Graft Substitutes, India, Volume (Units) by Segment, Forecast, 2010-2017 116
Table 74: Bone Graft Substitutes, India, Average Price ($), Historic, 2003-2010 117
Table 75: Bone Graft Substitutes, India, Average Price ($), Forecast, 2010-2017 117
Table 76: Viscosupplementation, India, Revenue ($m), Historic, 2003-2010 118
Table 77: Viscosupplementation, India, Revenue ($m), Forecast, 2010-2017 119
Table 78: Viscosupplementation, India, Volume (Units), Historic, 2003-2010 120
Table 79: Viscosupplementation, India, Volume (Units), Forecast, 2010-2017 121
Table 80: Viscosupplementation, India, Average Price ($), Historic, 2003-2010 122
Table 81: Viscosupplementation, India, Average Price ($), Forecast, 2010-2017 122
Table 82: Bone Allografts, India, Revenue ($m), Historic, 2003-2010 123
Table 83: Bone Allografts, India, Revenue ($m), Forecast, 2010-2017 124
Table 84: Bone Growth Stimulators, India, Revenue ($m), Historic, 2003-2010 125
Table 85: Bone Growth Stimulators, India, Revenue ($m), Forecast, 2010-2017 126
Table 86: Bone Growth Stimulators, India, Volume (Units), Historic, 2003-2010 127
Table 87: Bone Growth Stimulators, India, Volume (Units), Forecast, 2010-2017 128
Table 88: Bone Growth Stimulators, India, Average Price ($), Historic, 2003-2010 129
Table 89: Bone Growth Stimulators, India, Average Price ($), Forecast, 2010-2017 129
Table 90: Orthobiologics, India, Distribution Share by Revenue ($m), 2009-2010 130
Table 91: Orthobiologics, India, Company Share by Revenue ($m), 2009-2010 132
Table 92: Orthobiologics, China, Overall Revenue ($m), 2003-2017 134
Table 93: Orthobiologics, China, Overall Revenue ($m), Historic, 2003-2010 136
Table 94: Orthobiologics, China, Overall Revenue ($m), Forecast, 2010-2017 138
Table 95: Orthobiologics, China, Category Volume (Units), 2003-2017 139
Table 96: Orthobiologics, China, Category Volume (Units), Historic, 2003-2010 141
Table 97: Orthobiologics, China, Category Volume (Units), Forecast, 2010-2017 143
Table 98: Bone Graft Substitutes, China, Revenue ($m) by Segment, Historic, 2003-2010 145
Table 99: Bone Graft Substitutes, China, Revenue ($m) by Segment, Forecast, 2010-2017 147
Table 100: Bone Graft Substitutes, China, Volume (Units) by Segment, Historic, 2003-2010 149
Table 101: Bone Graft Substitutes, China, Volume (Units) by Segment, Forecast, 2010-2017 151
Table 102: Bone Graft Substitutes, China, Average Price ($), Historic, 2003-2010 152
Table 103: Bone Graft Substitutes, China, Average Price ($), Forecast, 2010-2017 152
Table 104: Bone Allografts, China, Revenue ($m), Historic, 2003-2010 153
Table 105: Bone Allografts, China, Revenue ($m) by Segment, Forecast, 2010-2017 154
Table 106: Viscosupplementation, China, Revenue ($m), Historic, 2003-2010 155
Table 107: Viscosupplementation, China, Revenue ($m), Forecast, 2010-2017 156
Table 108: Viscosupplementation, China, Volume (Units), Historic, 2003-2010 157
Table 109: Viscosupplementation, China, Volume (Units), Forecast, 2010-2017 158
Table 110: Viscosupplementation, China, Average Price ($), Historic, 2003-2010 159
Table 111: Viscosupplementation, China, Average Price ($), Forecast, 2010-2017 159
Table 112: Bone Growth Stimulators, China, Revenue ($m), Historic, 2003-2010 160
Table 113: Bone Growth Stimulators, China, Revenue ($m), Forecast, 2010-2017 161
Table 114: Bone Growth Stimulators, China, Volume (Units), Historic, 2003-2010 162
Table 115: Bone Growth Stimulators, China, Volume (Units), Forecast, 2010-2017 163
Table 116: Bone Growth Stimulators, China, Average Price ($), Historic, 2003-2010 164
Table 117: Bone Growth Stimulators, China, Average Price ($), Forecast, 2010-2017 164
Table 118: Orthobiologics, China, Distribution Share by Revenue ($m), 2009-2010 165
Table 119: Orthobiologics, China, Company Share by Revenue ($m), 2009-2010 167
Table 120: Orthobiologics, South Africa, Overall Revenue ($m), 2003-2017 169
Table 121: Orthobiologics, South Africa, Overall Revenue ($m), Historic, 2003-2010 171
Table 122: Orthobiologics, South Africa, Overall Revenue ($m), Forecast, 2010-2017 173
Table 123: Orthobiologics, South Africa, Category Volume (Units), 2003-2017 174
Table 124: Orthobiologics, South Africa, Category Volume (Units), Historic, 2003-2010 176
Table 125: Orthobiologics, South Africa, Category Volume (Units), Forecast, 2010-2017 178
Table 126: Viscosupplementation, South Africa, Revenue ($m), Historic, 2003-2010 179
Table 127: Viscosupplementation, South Africa, Revenue ($m), Forecast, 2010-2017 180
Table 128: Viscosupplementation, South Africa, Volume (Units), Historic, 2003-2010 181
Table 129: Viscosupplementation, South Africa, Volume (Units), Forecast, 2010-2017 182
Table 130: Viscosupplementation, South Africa, Average Price ($), Historic, 2003-2010 183
Table 131: Viscosupplementation, South Africa, Average Price ($), Forecast, 2010-2017 183
Table 132: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 185
Table 133: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 187
Table 134: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Historic, 2003-2010 189
Table 135: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Forecast, 2010-2017 190
Table 136: Bone Graft Substitutes, South Africa, Average Price ($), Historic, 2003-2010 191
Table 137: Bone Graft Substitutes, South Africa, Average Price ($), Forecast, 2010-2017 191
Table 138: Bone Allografts, South Africa, Revenue ($m), Historic, 2003-2010 192
Table 139: Bone Allografts, South Africa, Revenue ($m), Forecast, 2010-2017 193
Table 140: Bone Growth Stimulators, South Africa, Revenue ($m), Historic, 2003-2010 194
Table 141: Bone Growth Stimulators, South Africa, Revenue ($m), Forecast, 2010-2017 195
Table 142: Bone Growth Stimulators, South Africa, Volume (Units), Historic, 2003-2010 196
Table 143: Bone Growth Stimulators, South Africa, Volume (Units), Forecast, 2010-2017 197
Table 144: Bone Growth Stimulators, South Africa, Average Price ($), Historic, 2003-2010 198
Table 145: Bone Growth Stimulators, South Africa, Average Price ($), Forecast, 2010-2017 198
Table 146: Orthobiologics, South Africa, Distribution Share by Revenue ($m), 2009-2010 199
Table 147: Orthobiologics, South Africa, Company Share by Revenue ($m), 2009-2010 201
Table 148: DePuy, Inc., Revenue ($m), BRICS Orthobiologics Market, 2010 203
Table 149: Genzyme Corporation, Revenue ($m), BRICS Orthobiologics Market, 2010 205
Table 150: Synthes, Inc., Revenue ($m), BRICS Orthobiologics Market, 2010 207
Table 151: Orthofix International N.V., Revenue ($m), BRICS Orthobiologics Market, 2010 209
Table 152: Medtronic, Inc., Revenue ($m), BRICS Orthobiologics Market, 2010 211
Table 153: Biomet, Inc., Revenue ($m), BRICS Orthobiologics Market, 2010 213
Table 154: DJO Incorporated Revenue ($m), BRICS Orthobiologics Market, 2010 215
Table 155: Smith & Nephew Plc, Revenue ($m), BRICS Orthobiologics Market, 2010 217
Table 156: Baxter International Inc., Revenue ($m), BRICS Orthobiologics Market, 2010 219
Table 157: Stryker Corporation, Revenue ($m), BRICS Orthobiologics Market, 2010 221
Table 158: Globus Medical, Inc., Revenue ($m), BRICS Orthobiologics Market, 2010 222
Table 159: Wright Medical Group, Inc., Revenue ($m), BRICS Orthobiologics Market, 2010 224
Table 160: USD to Local Currency, BRICS, Average Exchange Rate, 2003-2010 233

1.2 List of Figures

Figure 1: Orthobiologics, BRICS, Overall Revenue ($m), 2003-2017 18
Figure 2: Orthobiologics, BRICS, Overall Revenue ($m), Historic, 2003-2010 20
Figure 3: Orthobiologics, BRICS, Overall Revenue ($m), Forecast, 2010-2017 22
Figure 4: Orthobiologics, BRICS, Category Volume (Units), 2003-2017 24
Figure 5: Orthobiologics, BRICS, Category Volume (Units), Historic, 2003-2010 25
Figure 6: Orthobiologics, BRICS, Category Volume (Units), Forecast, 2010-2017 27
Figure 7: Orthobiologics, BRICS, Company share (%), 2010 29
Figure 8: Orthobiologics, Brazil, Overall Revenue ($m), 2003-2017 31
Figure 9: Orthobiologics, Brazil, Overall Revenue ($m), Historic, 2003-2010 33
Figure 10: Orthobiologics, Brazil, Overall Revenue ($m), Forecast, 2010-2017 35
Figure 11: Orthobiologics, Brazil, Category Volume (Units), 2003-2017 37
Figure 12: Orthobiologics, Brazil, Category Volume (Units), Historic, 2003-2010 38
Figure 13: Orthobiologics, Brazil, Category Volume (Units), Forecast, 2010-2017 40
Figure 14: Bone Allografts, Brazil, Revenue ($m), Historic, 2003-2010 41
Figure 15: Bone Allografts, Brazil, Revenue ($m), Forecast, 2010-2017 42
Figure 16: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, Historic, 2003-2010 43
Figure 17: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, Forecast, 2010-2017 45
Figure 18: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Historic, 2003-2010 47
Figure 19: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Forecast, 2010-2017 49
Figure 20: Viscosupplementation, Brazil, Revenue ($m), Historic, 2003-2010 52
Figure 21: Viscosupplementation, Brazil, Revenue ($m), Forecast, 2010-2017 53
Figure 22: Viscosupplementation, Brazil, Volume (Units), Historic, 2003-2010 54
Figure 23: Viscosupplementation, Brazil, Volume (Units), Forecast, 2010-2017 55
Figure 24: Bone Growth Stimulators, Brazil, Revenue ($m), Historic, 2003-2010 57
Figure 25: Bone Growth Stimulators, Brazil, Revenue ($m), Forecast, 2010-2017 58
Figure 26: Bone Growth Stimulators, Brazil, Volume (Units), Historic, 2003-2010 59
Figure 27: Bone Growth Stimulators, Brazil, Volume (Units), Forecast, 2010-2017 60
Figure 28: Orthobiologics, Brazil, Company Share (%), 2010 63
Figure 29: Orthobiologics, Russian Federation, Overall Revenue ($m), 2003-2017 65
Figure 30: Orthobiologics, Russian Federation, Overall Revenue ($m), Historic, 2003-2010 67
Figure 31: Orthobiologics, Russian Federation, Overall Revenue ($m), Forecast, 2010-2017 69
Figure 32: Orthobiologics, Russian Federation, Category Volume (Units), 2003-2017 71
Figure 33: Orthobiologics, Russian Federation, Category Volume (Units), Historic, 2003-2010 72
Figure 34: Orthobiologics, Russian Federation, Category Volume (Units), Forecast, 2010-2017 74
Figure 35: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 76
Figure 36: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 78
Figure 37: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Historic, 2003-2010 80
Figure 38: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Forecast, 2010-2017 82
Figure 39: Bone Allografts, Russian Federation, Revenue ($m), Historic, 2003-2010 85
Figure 40: Bone Allografts, Russian Federation, Revenue ($m), Forecast, 2010-2017 86
Figure 41: Viscosupplementation, Russian Federation, Revenue ($m), Historic, 2003-2010 87
Figure 42: Viscosupplementation, Russian Federation, Revenue ($m), Forecast, 2010-2017 88
Figure 43: Viscosupplementation, Russian Federation, Volume (Units), Historic, 2003-2010 89
Figure 44: Viscosupplementation, Russian Federation, Volume (Units), Forecast, 2010-2017 90
Figure 45: Bone Growth Stimulators, Russian Federation, Revenue ($m), Historic, 2003-2010 92
Figure 46: Bone Growth Stimulators, Russian Federation, Revenue ($m), Forecast, 2010-2017 93
Figure 47: Bone Growth Stimulators, Russian Federation, Volume (Units), Historic, 2003-2010 94
Figure 48: Bone Growth Stimulators, Russian Federation, Volume (Units), Forecast, 2010-2017 95
Figure 49: Orthobiologics, Russian Federation, Company Share (%), 2010 98
Figure 50: Orthobiologics, India, Overall Revenue ($m), 2003-2017 100
Figure 51: Orthobiologics, India, Overall Revenue ($m), Historic, 2003-2010 102
Figure 52: Orthobiologics, India, Overall Revenue ($m), Forecast, 2010-2017 104
Figure 53: Orthobiologics, India, Category Volume (Units), 2003-2017 106
Figure 54: Orthobiologics, India, Category Volume (Units), Historic, 2003-2010 107
Figure 55: Orthobiologics, India, Category Volume (Units), Forecast, 2010-2017 109
Figure 56: Bone Graft Substitutes, India, Revenue ($m) by Segment, Historic, 2003-2010 110
Figure 57: Bone Graft Substitutes, India, Revenue ($m) by Segment, Forecast, 2010-2017 112
Figure 58: Bone Graft Substitutes, India, Volume (Units) by Segment, Historic, 2003-2010 114
Figure 59: Bone Graft Substitutes, India, Volume (Units) by Segment, Forecast, 2010-2017 116
Figure 60: Viscosupplementation, India, Revenue ($m), Historic, 2003-2010 118
Figure 61: Viscosupplementation, India, Revenue ($m), Forecast, 2010-2017 119
Figure 62: Viscosupplementation, India, Volume (Units), Historic, 2003-2010 120
Figure 63: Viscosupplementation, India, Volume (Units), Forecast, 2010-2017 121
Figure 64: Bone Allografts, India, Revenue ($m), Historic, 2003-2010 123
Figure 65: Bone Allografts, India, Revenue ($m), Forecast, 2010-2017 124
Figure 66: Bone Growth Stimulators, India, Revenue ($m), Historic, 2003-2010 125
Figure 67: Bone Growth Stimulators, India, Revenue ($m), Forecast, 2010-2017 126
Figure 68: Bone Growth Stimulators, India, Volume (Units), Historic, 2003-2010 127
Figure 69: Bone Growth Stimulators, India, Volume (Units), Forecast, 2010-2017 128
Figure 70: Orthobiologics, India, Company Share (%), 2010 131
Figure 71: Orthobiologics, China, Overall Revenue ($m), 2003-2017 133
Figure 72: Orthobiologics, China, Overall Revenue ($m), Historic, 2003-2010 135
Figure 73: Orthobiologics, China, Overall Revenue ($m), Forecast, 2010-2017 137
Figure 74: Orthobiologics, China, Category Volume (Units), 2003-2017 139
Figure 75: Orthobiologics, China, Category Volume (Units), Historic, 2003-2010 140
Figure 76: Orthobiologics, China, Category Volume (Units), Forecast, 2010-2017 142
Figure 77: Bone Graft Substitutes, China, Revenue ($m) by Segment, Historic, 2003-2010 144
Figure 78: Bone Graft Substitutes, China, Revenue ($m) by Segment, Forecast, 2010-2017 146
Figure 79: Bone Graft Substitutes, China, Volume (Units) by Segment, Historic, 2003-2010 148
Figure 80: Bone Graft Substitutes, China, Volume (Units) by Segment, Forecast, 2010-2017 150
Figure 81: Bone Allografts, China, Revenue ($m), Historic, 2003-2010 153
Figure 82: Bone Allografts, China, Revenue ($m), Forecast, 2010-2017 154
Figure 83: Viscosupplementation, China, Revenue ($m), Historic, 2003-2010 155
Figure 84: Viscosupplementation, China, Revenue ($m), Forecast, 2010-2017 156
Figure 85: Viscosupplementation, China, Volume (Units), Historic, 2003-2010 157
Figure 86: Viscosupplementation, China, Volume (Units), Forecast, 2010-2017 158
Figure 87: Bone Growth Stimulators, China, Revenue ($m), Historic, 2003-2010 160
Figure 88: Bone Growth Stimulators, China, Revenue ($m), Forecast, 2010-2017 161
Figure 89: Bone Growth Stimulators, China, Volume (Units), Historic, 2003-2010 162
Figure 90: Bone Growth Stimulators, China, Volume (Units), Forecast, 2010-2017 163
Figure 91: Orthobiologics, China, Company Share (%), 2010 166
Figure 92: Orthobiologics, South Africa, Overall Revenue ($m), 2003-2017 168
Figure 93: Orthobiologics, South Africa, Overall Revenue ($m), Historic, 2003-2010 170
Figure 94: Orthobiologics, South Africa, Overall Revenue ($m), Forecast, 2010-2017 172
Figure 95: Orthobiologics, South Africa, Category Volume (Units), 2003-2017 174
Figure 96: Orthobiologics, South Africa, Category Volume (Units), Historic, 2003-2010 175
Figure 97: Orthobiologics, South Africa, Category Volume (Units), Forecast, 2010-2017 177
Figure 98: Viscosupplementation, South Africa, Revenue ($m), Historic, 2003-2010 179
Figure 99: Viscosupplementation, South Africa, Revenue ($m), Forecast, 2010-2017 180
Figure 100: Viscosupplementation, South Africa, Volume (Units), Historic, 2003-2010 181
Figure 101: Viscosupplementation, South Africa, Volume (Units), Forecast, 2010-2017 182
Figure 102: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 184
Figure 103: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 186
Figure 104: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Historic, 2003-2010 188
Figure 105: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Forecast, 2010-2017 190
Figure 106: Bone Allografts, South Africa, Revenue ($m), Historic, 2003-2010 192
Figure 107: Bone Allografts, South Africa, Revenue ($m), Forecast, 2010-2017 193
Figure 108: Bone Growth Stimulators, South Africa, Revenue ($m), Historic, 2003-2010 194
Figure 109: Bone Growth Stimulators, South Africa, Revenue ($m), Forecast, 2010-2017 195
Figure 110: Bone Growth Stimulators, South Africa, Volume (Units), Historic, 2003-2010 196
Figure 111: Bone Growth Stimulators, South Africa, Volume (Units), Forecast, 2010-2017 197
Figure 112: Orthobiologics, South Africa, Company Share (%), 2010 200
Figure 113: DePuy, Inc., Company Share (%), BRICS Orthobiologics Market, 2010 203
Figure 114: Genzyme Corporation, Company Share (%), BRICS Orthobiologics Market, 2010 205
Figure 115: Synthes, Inc., Company Share (%), BRICS Orthobiologics Market, 2010 207
Figure 116:

Talk to Robyn

00 1 718 213 49 04

Send Your Request

Follow

Add to circles Subscribe to our RSS feeds!

Biomaterial Industry in Africa : Latest Reports

Orthobiologics: Global Market Prospects 2012-2022

$ 2 654
Industry report
March 2012
by Visiongain

Report Details Our new report Orthobiologics: Global Market Prospects 2012-2022 covers the trends in the orthobiologics market, a promising segment of the orthopaedic sector. The orthobiologics market ...

Orthobiologics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

$ 3 500
Industry report
August 2011
by Global Data

Orthobiologics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Summary GlobalData's new report, ?Orthobiologics - Global Pipeline Analysis, Competitive Landscape and Market ...

Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics

$ 3 500
Industry report
June 2011
by GBI Research

Summary GBI Research's new report, ?Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics? provides key data, information and analysis ...